sábado, 29 de agosto de 2026

FDA: aprueba la primera terapia para cáncer pancreático metastásico

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer

No hay comentarios:

Publicar un comentario